fda approves semaglutide First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity FDA Approves GLP-1 Pill for

For the scenario of "Type 2 diabetes glycemic control," research data suggests Liraglutide may be more relevant

About the author Rekha Kumar, MD, MS, is the head of medical affairs at Found

How tirzepatide microdosing compares to semaglutide microdosing If you are weighing semaglutide against tirzepatide , the microdosing comparison adds another dimension

Dry mouth - a persistent feeling of dryness in the mouth and throat that isn't immediately relieved by drinking water - is a reported side effect of Mounjaro that's separate from generalised thirst

In the SUMMIT trial, tirzepatide reduced the composite risk of cardiovascular death or worsening heart failure in patients with obesity-related HFpEF and also improved health status (Packer et al., 2025)